Hendrik B Sager1, Timo Heidt1, Maarten Hulsmans1, Partha Dutta1, Gabriel Courties1, Matthew Sebas1, Gregory R Wojtkiewicz1, Benoit Tricot1, Yoshiko Iwamoto1, Yuan Sun1, Ralph Weissleder1, Peter Libby1, Filip K Swirski1, Matthias Nahrendorf2. 1. From Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Simches Research Building, Boston, MA (H.B.S., T.H., M.H., P.D., G.C., M.S., G.R.W., B.T., Y.I., Y.S., R.W., F.K.S., M.N.); Department of Systems Biology, Harvard Medical School, Boston, MA (R.W.); and Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA (P.L.). 2. From Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Simches Research Building, Boston, MA (H.B.S., T.H., M.H., P.D., G.C., M.S., G.R.W., B.T., Y.I., Y.S., R.W., F.K.S., M.N.); Department of Systems Biology, Harvard Medical School, Boston, MA (R.W.); and Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA (P.L.). mnahrendorf@mgh.harvard.edu.
Abstract
BACKGROUND: Myocardial infarction (MI) is an ischemic wound that recruits millions of leukocytes. MI-associated blood leukocytosis correlates inversely with patient survival, yet the signals driving heightened leukocyte production after MI remain incompletely understood. METHODS AND RESULTS: With the use of parabiosis surgery, this study shows that soluble danger signals, among them interleukin-1β, increase bone marrow hematopoietic stem cell proliferation after MI. Data obtained in bone marrow reconstitution experiments reveal that interleukin-1β enhances hematopoietic stem cell proliferation by both direct actions on hematopoietic cells and through modulation of the bone marrow's hematopoietic microenvironment. An antibody that neutralizes interleukin-1β suppresses these effects. Anti-interleukin-1β treatment dampens the post-MI increase in hematopoietic stem cell proliferation. Consequently, decreased leukocyte numbers in the blood and infarct reduce inflammation and diminish post-MI heart failure in ApoE(-/-) mice with atherosclerosis. CONCLUSIONS: The presented insight into post-MI bone marrow activation identifies a mechanistic target for muting inflammation in the ischemically damaged heart.
BACKGROUND:Myocardial infarction (MI) is an ischemic wound that recruits millions of leukocytes. MI-associated blood leukocytosis correlates inversely with patient survival, yet the signals driving heightened leukocyte production after MI remain incompletely understood. METHODS AND RESULTS: With the use of parabiosis surgery, this study shows that soluble danger signals, among them interleukin-1β, increase bone marrow hematopoietic stem cell proliferation after MI. Data obtained in bone marrow reconstitution experiments reveal that interleukin-1β enhances hematopoietic stem cell proliferation by both direct actions on hematopoietic cells and through modulation of the bone marrow's hematopoietic microenvironment. An antibody that neutralizes interleukin-1β suppresses these effects. Anti-interleukin-1β treatment dampens the post-MI increase in hematopoietic stem cell proliferation. Consequently, decreased leukocyte numbers in the blood and infarct reduce inflammation and diminish post-MI heart failure in ApoE(-/-) mice with atherosclerosis. CONCLUSIONS: The presented insight into post-MI bone marrow activation identifies a mechanistic target for muting inflammation in the ischemically damaged heart.
Authors: Laurent Yvan-Charvet; Tamara Pagler; Emmanuel L Gautier; Serine Avagyan; Read L Siry; Seongah Han; Carrie L Welch; Nan Wang; Gwendalyn J Randolph; Hans W Snoeck; Alan R Tall Journal: Science Date: 2010-05-20 Impact factor: 47.728
Authors: Arin B Aurora; Enzo R Porrello; Wei Tan; Ahmed I Mahmoud; Joseph A Hill; Rhonda Bassel-Duby; Hesham A Sadek; Eric N Olson Journal: J Clin Invest Date: 2014-02-24 Impact factor: 14.808
Authors: Marieke A G Essers; Sandra Offner; William E Blanco-Bose; Zoe Waibler; Ulrich Kalinke; Michel A Duchosal; Andreas Trumpp Journal: Nature Date: 2009-02-11 Impact factor: 49.962
Authors: Megan T Baldridge; Katherine Y King; Nathan C Boles; David C Weksberg; Margaret A Goodell Journal: Nature Date: 2010-06-10 Impact factor: 49.962
Authors: Timo Heidt; Hendrik B Sager; Gabriel Courties; Partha Dutta; Yoshiko Iwamoto; Alex Zaltsman; Constantin von Zur Muhlen; Christoph Bode; Gregory L Fricchione; John Denninger; Charles P Lin; Claudio Vinegoni; Peter Libby; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf Journal: Nat Med Date: 2014-06-22 Impact factor: 53.440
Authors: José J Fuster; Susan MacLauchlan; María A Zuriaga; Maya N Polackal; Allison C Ostriker; Raja Chakraborty; Chia-Ling Wu; Soichi Sano; Sujatha Muralidharan; Cristina Rius; Jacqueline Vuong; Sophia Jacob; Varsha Muralidhar; Avril A B Robertson; Matthew A Cooper; Vicente Andrés; Karen K Hirschi; Kathleen A Martin; Kenneth Walsh Journal: Science Date: 2017-01-19 Impact factor: 47.728
Authors: Hendrik B Sager; Maarten Hulsmans; Kory J Lavine; Marina B Moreira; Timo Heidt; Gabriel Courties; Yuan Sun; Yoshiko Iwamoto; Benoit Tricot; Omar F Khan; James E Dahlman; Anna Borodovsky; Kevin Fitzgerald; Daniel G Anderson; Ralph Weissleder; Peter Libby; Filip K Swirski; Matthias Nahrendorf Journal: Circ Res Date: 2016-07-21 Impact factor: 17.367